{"nct_id":"NCT07140900","title":"Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-10-07","start_date_type":"ESTIMATED","primary_completion_date":"2028-03-27","primary_completion_date_type":"ESTIMATED","completion_date":"2030-03-30","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AMGN"]}